<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) might be organized hierarchically and contain a subpopulation of tumorigenic, putative <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells that are CD133 positive </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the biological and genetic characteristics of such cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines were sorted in CD133 positive and negative fractions </plain></SENT>
<SENT sid="3" pm="."><plain>The respective genetic aberration profiles were studied using array comparative genomic hybridization (aCGH) and expression profiling </plain></SENT>
<SENT sid="4" pm="."><plain>Tumorigenicity for each cellular population was tested by injection into <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, we compared CD133+ and CD133- cells of 12 primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> using laser capture microdissection and aCGH </plain></SENT>
<SENT sid="6" pm="."><plain>Three of five <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines displayed both CD133+ and CD133- cells, but tumorigenicity of these subfractions did not differ significantly and aCGH revealed essentially identical genomic imbalances </plain></SENT>
<SENT sid="7" pm="."><plain>However, 96 genes were differentially expressed between the two populations </plain></SENT>
<SENT sid="8" pm="."><plain>Array comparative genomic hybridization analysis after laser capture microdissection of CD133+ and CD133- areas in primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> revealed genetic differences in 7 of 12 cases </plain></SENT>
<SENT sid="9" pm="."><plain>The use of cell lines for studying genomic alterations that define <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell characteristics, therefore, seems questionable </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, CD133+ cells in primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> samples showed a unique genomic aberration profile </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, our data suggest that CD133 positivity defines a genetically distinct cellular compartment in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, which potentially includes <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> initiating cells </plain></SENT>
</text></document>